Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire 12

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Body image scores significantly improved from baseline after native tissue vaginal prolapse repair, with clinically significant improvement (exceeding estimated MID of 13.0 on normalized 100-point sca

Effect: improvement; Statistically (p<0.01) and clinically significant improvement from baseline to 6 months (exceeding estimated MID of 13.0)

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%

Native tissue vaginal prolapse repair with midurethral sling results in clinically and statistically significant improvements in sexual function (PISQ-12) and decreased dyspareunia rates (25% to 16%)

Effect: improvement; PISQ-12 improvement exceeded MID of 6 points at 6 and 12 months, nearly reached MID at 24 months; dyspareunia decreased from 25% to 16%